Recursion Feb 19, 2026 Nvidia Dumped It, Cathie Wood Bought It. A Pharma Stock Is Splitting the Market. - Barron's
Recursion Jan 25, 2026 Will Nvidia-Backed BioHive-2 and Big Pharma Alliances Redefine Recursion Pharmaceuticals' (RXRX) Narrative - Yahoo Finance
Recursion Jan 1, 2026 Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy. - The Motley Fool
Recursion Dec 1, 2025 Recursion’s Incoming CEO on Turning AI Drugs Into Clinical Proof Points - Genetic Engineering and Biotechnology News
Recursion Nov 21, 2025 Recursion seeks to deliver results, and a VC sees a wave of M&A coming - statnews.com
Recursion Nov 21, 2025 Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results - statnews.com